How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

439 results for

Episodic Atrial Fibrillation Home Management

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Are direct oral anticoagulants (DOACs) more effective in lowering the risk of significant bleeding episodes in patients with non valvular atrial fibrillation?

Are direct oral anticoagulants (DOACs) more effective in lowering the risk of significant bleeding episodes in patients with non valvular atrial fibrillation? Q&A - Are direct oral anticoagulants (DOACs) more effective in lowering the risk of significant bleeding episodes in patients with non valvular atrial fibrillation? - Trip Database NEW! Google+ Find evidence fast ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT (...) of significant bleeding episodes in patients with non valvular atrial fibrillation? Please log in to post a reply Your response: Submit my answer 1 answer Notes about answers If you see something you feel is wrong, don’t criticise (that misses the point of Triple) courteously and supportively give a counter answer. Answers given should be in good faith, but they should not be considered definitive, be critical. We do not endorse or verify content posted by users. Thanks for your response, Thanks for your

2020 Trip Community Q&A

2. Episodic Atrial Fibrillation Home Management

Episodic Atrial Fibrillation Home Management Episodic Atrial Fibrillation Home Management Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer (...) Administration 4 Episodic Atrial Fibrillation Home Management Episodic Atrial Fibrillation Home Management Aka: Episodic Atrial Fibrillation Home Management , Intermittent Atrial Fibrillation Pill in the Pocket , Paroxysmal Atrial Fibrillation Home Management From Related Chapters II. Indications Episodic Fewer than 12 episodes yearly III. Contraindications or other structural heart disease IV. Protocol (Initiated by Cardiology) Cardiologists prescribe agent (Tambicor) 200-300 mg (Rhythmol) 600 mg Patient

2018 FP Notebook

3. Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association Full Text available with Trip Pro

tachyarrhythmias , atrial high-rate episodes , subclinical atrial fibrillation , silent atrial fibrillation , and subclinical atrial tachyarrhythmias . The document was peer reviewed by official external reviewers representing experts in population-based, clinical, and translational research on AF. Definition of AF Burden In the simplest sense, AF burden refers to the amount of AF that an individual has. By considering AF burden, we regard AF as a quantitative entity and move beyond merely treating AF (...) on clinical risk factors, not on AF pattern. Similarly, both the EORP-AF (EURObservational Research Programme–Atrial Fibrillation) General Pilot Registry and the J-RHYTHM (Japanese Rhythm Management Trial for Atrial Fibrillation) Registry demonstrated higher death rates with nonparoxysmal AF; however, in the multivariable Cox model, nonparoxysmal AF was not an independent predictor of death during follow-up. , In the Euro Heart Survey, paroxysmal AF had comparable risk for thromboembolic events

2018 American Heart Association

4. Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary care

Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary care L Lead-I ECG de ead-I ECG devices for detecting vices for detecting symptomatic atrial fibrillation using symptomatic atrial fibrillation using single time point testing in primary care single time point testing in primary care Diagnostics guidance Published: 8 May 2019 www.nice.org.uk/guidance/dg35 © NICE 2019. All rights reserved. Subject to Notice of rights (https (...) point testing in primary care (DG35) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 3 of 40This guidance should be read in conjunction with MIB35. 1 1 Recommendations Recommendations 1.1 There is not enough evidence to recommend the routine adoption of lead-I electrocardiogram (ECG) devices (imPulse, Kardia Mobile, MyDiagnostick and Zenicor-ECG) to detect atrial fibrillation when used for single time point testing

2019 National Institute for Health and Clinical Excellence - Diagnostics Guidance

5. Atrial Fibrillation ? Diagnosis and Management

, clinic pharmacy, and at home). References: 1. e-CPS [Internet]. Ottawa, ON: Canadian Pharmacists Association; 2014 [cited 2014/08/20]. 2. Health Canada Drug Product Database Product Monographs. Ottawa, ON: Health Canada; 2014 [cited 2014/08/20]. 3. e-Therapeutics [Internet]. Ottawa, ON: Canadian Pharmacists Association; 2014 [cited 2014/08/20]. BCGuidelines.ca: Atrial Fibrillation – Diagnosis and Management: Appendix G (2015) 4 (...) Atrial Fibrillation ? Diagnosis and Management Guidelines & Protocols Advisory Committee Atrial Fibrillation – Diagnosis and Management Effective Date: April 1, 2015 Scope This guideline provides recommendations for the diagnosis and management of atrial fibrillation (AF) including the primary prevention of stroke and transient ischemic attack (TIA) in adults aged =19 years. This guideline focuses primarily on non-valvular AF . This guideline is part of the BCGuidelines.ca – Stroke and Atrial

2015 Clinical Practice Guidelines and Protocols in British Columbia

6. HRS White Paper on Atrial Fibrillation Centers of Excellence: Rationale, Considerations, and Goals

. In other cases, patients with AF are managed by noncardiovascular specialists who may have difficulty staying Piccini et al Atrial fibrillation centers of excellence Page 5 of 72 up to date on guideline-directed treatment of AF. It is our belief that a patient-centered, multidisciplinary, and integrated model of care can address all aspects of AF in a manner that should create greater value by improving clinical outcomes and decreasing costs. 26,27 Opportunities to improve care of AF (...) , integrated AF clinic approach to AF management, with a focus on risk factor management, have resulted in reductions in wait times for specialist assessment, emergency department visits, hospitalizations, and mortality. 52 The development of these clinics requires expert staff, collaboration, and special resources that carry significant costs. These requirements limit the widespread initiation of these centers. Piccini et al Atrial fibrillation centers of excellence Page 7 of 72 Section 3 Building

2020 Heart Rhythm Society

7. Atrial Fibrillation (Focused Update)

Atrial Fibrillation (Focused Update) Accepted Manuscript 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation Craig T. January, MD, PhD, FACC, Chair, Writing Group, L. Samuel Wann, MD, MACC, FAHA, Vice Chair, Writing Group, Hugh Calkins, MD, FACC, FAHA, FHRS, Writing Group Member, Lin Y. Chen, MD, MS, FACC, FAHA, FHRS, Writing Group Member, Joaquin E. Cigarroa, MD, FACC, Writing Group Member, Joseph C. Cleveland, Jr., MD, FACC (...) the content, and all legal disclaimers that apply to the journal pertain.MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT January CT, et al. 2019 Focused Update on Atrial Fibrillation Page 1 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society Developed in Collaboration With the Society of Thoracic

2019 American College of Cardiology

8. Atrial Fibrillation Full Text available with Trip Pro

) Reuse portions or extracts from the article in other works Not Permitted Sell or re-use for commercial purposes Distribute translations or adaptations of the article | ---- Figure 1 Management of atrial high-rate episodes. ---- | ---- Figure 2 Electrical cardioversion. ---- | ---- Figure 3 Acute rate control of atrial fibrillation with rapid ventricular response. ---- | ---- Figure 4 Chronic rate control of atrial fibrillation with rapid ventricular response. ---- | ---- Figure 5 Long term rhythm (...) . Arch Intern Med . 2012 ; 172 : 739–741 | | | ] [14] . Hence, the societal and healthcare costs of AF will continue to escalate unless AF and its risk factors and complications are prevented and treated effectively. 3.2. The Process of Developing the 2018 Atrial Fibrillation Guidelines These clinical guidelines for the management of AF seek to provide guidance regarding the clinical care of patients with AF. This is the first Australian guideline on this topic. In late 2016, a partnership was formed

2018 Cardiac Society of Australia and New Zealand

9. Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report

disease, age 65-74 and sex category ABBREVIATIONS: ABC = Atrial ?brillation Better Care; ACS = acute coronary syndrome; ACTIVE W = Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events; ACUTE = Assessment of Cardioversion Using Transesophageal Echocardiog- raphy; AFFIRM= AtrialFibrillationFollow-upInvestigationofSinus Rhythm Management; AHRE = atrial high-rate episode; aPTT = activated partial thromboplastin time; ARISTOTLE = Apixaban for Reduction of Stroke and Other (...) -MI - Vascular death SR RCTs Cohort studies (Continued) chestjournal.org 1137TABLE1] (Continued) Section Question Patients Intervention Control Outcomes Methodology 5.5 Perioperative management of OACs (including devices) Atrial high rate episodes on devices or monitors How should VKA therapy be managed for AF patients undergoing surgery/invasive procedure? Patients with AF on OAC therapy “Bridging” therapy with LMWH or IV heparin No bridging therapy - Death - All stroke - Ischemic stroke

2018 American College of Chest Physicians

10. Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update

Appendix I. Expert Guidance and Review ES-1 Evidence Summary Introduction This systematic review is an update of an earlier report published in 2013 which evaluated questions related to stroke prevention in patients with atrial fibrillation (AF) and atrial flutter. Given evidence that has emerged since the publication of the 2013 report, this review focuses on updating and expanding the earlier work in three key areas: (1) evaluating the accuracy and utility of clinical tools and imaging tools (...) . If the incidence of AF increases at the same pace, then the projected number of adults with AF would be 15.9 million, a three-fold increase from 2000. 5 Management of AF involves three distinct areas, namely, rate control, rhythm control, and prevention of thromboembolic events. This review will focus on prevention of thromboembolic events. Atrial Fibrillation and Stroke Although generally not as immediately life-threatening as ventricular arrhythmias, AF is associated with significant morbidity and mortality

2018 Effective Health Care Program (AHRQ)

11. Blood & Clots Series: How do you choose an anticoagulant for stroke prevention in atrial fibrillation? Full Text available with Trip Pro

by , and uploaded by Rebecca Dang. References 1. Stiell IG, Scheuermeyer FX, Vadeboncoeur A, et al. CAEP Acute Atrial Fibrillation/Flutter Best Practices Checklist. C . 2018;20(03):334-342. doi: 2. Macle L, Cairns J, Leblanc K, et al. 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation. Can J Cardiol . 2016;32(10):1170-1185. [ ] 3. Foley T, Krantz M. CHAD is Dead: Pragmatic Utility of the CHA2DS2-VASc Score in Non-Valvular Atrial (...) Blood & Clots Series: How do you choose an anticoagulant for stroke prevention in atrial fibrillation? Blood & Clots Series: How do you choose an anticoagulant for stroke prevention in atrial fibrillation? - CanadiEM Blood & Clots Series: How do you choose an anticoagulant for stroke prevention in atrial fibrillation? In , by Kerstin de Wit October 23, 2018 All the content from the Blood & Clots series can be found . CanMEDS Roles addressed : Expert, health advocate, communicator Case

2018 CandiEM

12. Atrial Fibrillation: Guidelines For Management of Patients With

Atrial Fibrillation: Guidelines For Management of Patients With CLINICAL PRACTICE GUIDELINE: FULL TEXT 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society Developed in Collaboration With the Society of Thoracic Surgeons Writing Committee Members* Craig T. January, MD, PHD, FACC, Chair L. Samuel Wann, MD, MACC, FAHA, Vice Chair (...) guideline incorporates new and existing knowledge derived from published clinical trials, basic science, and comprehensive review articles, along with evolving treatment strategies and new drugs. This guideline supersedes the “ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation” (4) and the 2 subsequent focused updates from 2011 (5,6).In addition, the ACC, AHA, American College of Physicians, and American Academy of Family Physicians submitted a proposal to the Agency

2014 American College of Cardiology

13. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation Full Text available with Trip Pro

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies. By continuing to browse this site you (...) are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society , MD, PhD, FACC , MD, MACC, FAHA , MD, FACC, FAHA , MD, FACC, FAHA, FHRS , MD, FACC , MD, FACC , MD, FACC, FHRS , MD, PhD, FAHA , MB, ChB, FACC, FAHA , MD, FACC, FHRS , MD, FACC, FAHA, FHRS , MD

2014 American Heart Association

14. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary Full Text available with Trip Pro

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies (...) . By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society , MD, PhD, FACC , MD, MACC, FAHA , MD, FACC, FAHA , MD, FACC, FAHA, FHRS , MD, FACC , MD, FACC , MD, FACC, FHRS , MD, PhD, FAHA , MB, ChB

2014 American Heart Association

15. AliveCor Heart Monitor and AliveECG app for detecting atrial fibrillation

Monitor is portable, readings can be taken at any time of the day while the user goes about their normal activities. This increases the probability of an arrhythmic episode being detected and recorded. As a portable device, it can be used in any setting but is particularly designed for home use by people. AliveCor Heart Monitor and AliveECG app (Kardia Mobile) for detecting atrial fibrillation (MIB35) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms (...) coagulometers (the CoaguChek XS system and the INRatio2 PT/INR monitor) (2014) NICE diagnostics guidance 14 AliveCor Heart Monitor and AliveECG app (Kardia Mobile) for detecting atrial fibrillation (MIB35) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 17 of 32Atrial fibrillation: the management of atrial fibrillation (2014) NICE guideline CG180. Date for review: September 2016 Apixaban for preventing stroke and systemic

2015 National Institute for Health and Clinical Excellence - Advice

16. Screening for Atrial Fibrillation: 2017 European Heart Rhythm Association (EHRA) Consensus Document

Management) the presence or absence of symptoms associated with AF were not associated with differences in the risk of stroke or death, taking into account differences in baseline clinical parameters. 26 The negative prognostic implications of asymptomatic AF emerged in the EurObservational Research Programme-Atrial Fibrillation (EORP-AF) Pilot General Registry, where asymptomatic AF was commonly associated with elderly age, high burden of co- morbidities, and high thromboembolic risks, with higher 1 (...) Screening for Atrial Fibrillation: 2017 European Heart Rhythm Association (EHRA) Consensus Document Screeningforatrialfibrillation:aEuropean HeartRhythmAssociation(EHRA)consensus documentendorsedbytheHeartRhythm Society(HRS),AsiaPacificHeartRhythm Society(APHRS),andSociedad LatinoamericanadeEstimulaci onCard iaca y Electrofisiolog ia(SOLAECE) GeorgesH.Mairesse 1 *(Chair,Belgium),PatrickMoran 2 (Ireland), IsabelleC.VanGelder 3 (TheNetherlands),ChristianElsner 4 (Germany), MartenRosenqvist 5

2017 Heart Rhythm Society

17. Management of Atrial Fibrillation

Management of Atrial Fibrillation MOH/P/PAK/259.12(GU)STATEMENT OF INTENT This guideline is meant to be a guide for clinical practice, based on the best available evidence at the time of development. Adherence to this guideline may not necessarily guarantee the best outcome in every case. Every health care provider is responsible for the management of his/her unique patient based on the clinical picture presented by the patient and the management options available locally. This guideline (...) Guidelines for Atrial Fibrillation marked a milestone in the evolution of clinical practice guidelines and the delivery of care in cardiology. Specifically, these guidelines assist physicians in clinical decision making by describing a range of generally acceptable approaches for the diagnosis, management, and prevention of AF. Clinical Issues eg: AF assessment, best treatment strategy for acute AF & reduce risk of adverse outcomes from AF, best long term treatment strategy, management of AF in specific

2012 Ministry of Health, Malaysia

18. 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter Full Text available with Trip Pro

Documents Guidelines 2014 AHA/ACC/HRS Guidelines for the Management of Patients With Atrial Fibrillation 2013 ACCF/AHA Guideline for Management of Heart Failure Statements 2013 Treatment of Atrial Fibrillation , 2012 AHA/ASA Oral Antithrombotic Agents for the Prevention of Stroke in Nonvalvular Atrial Fibrillation: A Science Advisory for Healthcare Professionals 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation Recommended for Patient Selection (...) to the measure. Table 4. Revised Atrial Fibrillation Measures No. Care Setting Measure Title Rationale for Revisions PM-4 Outpatient CHA 2 DS 2 -VASc Risk Score Documented This measure was revised to reflect the update in the “2014 AHA/ACC/HRS Guideline for Management of Patients With Atrial Fibrillation” that recommends the use of the CHA 2 DS 2 -VASc score instead of the CHA 2 DS 2 . Additionally, this measure was revised to allow for a patient reason exception that reflects instances in which a patient

2016 American Heart Association

19. LATITUDE NXT Patient Management System for monitoring cardiac devices at home

System for monitoring cardiac devices at home (MIB67) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 12 of 23Rele Relevance to NICE guidance progr vance to NICE guidance programmes ammes NICE has issued the following guidance: Chronic heart failure in adults: management (2010) NICE guideline 108. Currently being updated Atrial fibrillation: management (2014) NICE guideline 180. Date for review: September 2016 (...) LATITUDE NXT Patient Management System for monitoring cardiac devices at home LA LATITUDE NXT P TITUDE NXT Patient Management System for atient Management System for monitoring cardiac de monitoring cardiac devices at home vices at home Medtech innovation briefing Published: 24 May 2016 nice.org.uk/guidance/mib67 pathways Summary Summary The LATITUDE NXT Patient Management System is a remote monitoring system for people with a compatible Boston Scientific implanted cardiac device. The system

2016 National Institute for Health and Clinical Excellence - Advice

20. Is Rhythm Control Better Than Rate Control for New-Onset Atrial Fibrillation in the Emergency Department?

Is Rhythm Control Better Than Rate Control for New-Onset Atrial Fibrillation in the Emergency Department? Systematic Review Snapshot TAKE-HOME MESSAGE In patients with new-onset atrial ?brillation and symptom onset within 48 hours, rhythm control is preferred over rate control if the patient is younger than 65 years. For patients with congestive heart failure, valvular heart disease, hypertension, or permanent atrial ?brillation, rate control remains the favored strategy. Is Rhythm Control (...) -quality trials (Table) were selected for their relevance to emergency physicians on the basis of a younger age pro?le, paroxysmal atrial ?brillation sub- type, and early presentation to health care providers within 7 days of symptom onset. 2-5 The Japanese Rhythm Management Trial for Atrial Fibrillation 5 trial holds the most relevance for the emergency department (ED), given the large number of patients younger than 65 years, its selection criteria closely mimicking an ED presentation of atrial

2015 Annals of Emergency Medicine Systematic Review Snapshots

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>